表紙
市場調查報告書

全球血小板凝集設備市場:2017年∼2021年

Global Platelet Aggregation Devices Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 531778
出版日期 內容資訊 英文 77 Pages
訂單完成後即時交付
價格
全球血小板凝集設備市場:2017年∼2021年 Global Platelet Aggregation Devices Market 2017-2021
出版日期: 2017年07月19日內容資訊: 英文 77 Pages
簡介

全球血小板凝集設備市場在2017年到2021年這段預測期間內,預計將以年複合成長率17.02%的速度成長。

本報告提供全球血小板凝集設備市場相關調查分析,提供市場概要,市場趨勢,市場規模等相關考察,及各產品種類,各終端用戶,各地區市場分析,並概括性分析、彙整供應商狀況等資訊。

第1章 摘要整理

第2章 調查的範圍

第3章 調查方法

第4章 簡介

第5章 市場的狀況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 市場區隔:各產品種類

  • 系統
  • 試劑
  • 配件,消耗品

第7章 市場區隔:各終端用戶

  • 醫院
  • 臨床檢驗室
  • 其他

第8章 各地區市場區隔

  • 南北美洲
  • 歐洲/中東/非洲
  • 亞太地區

第9章 決策架構

第10章 促進要素與課題

第11章 市場趨勢

  • 產學聯合的增加
  • 線上行銷服務的增加
  • 對自動血小板凝集實驗的關注
  • 輸血手術的增加

第12章 供應商狀況

  • 競爭模式

第13章 主要供應商分析

  • F. Hoffmann-La Roche
  • Haemonetics
  • Helena Laboratories
  • Instrumentation Laboratory
  • Siemens Healthineers
  • 其他的供應商

第14章 附錄

目錄
Product Code: IRTNTR13716

About Platelet Aggregation Devices

Platelet aggregation devices are used for diagnosis of inherited and acquired bleeding disorders and for monitoring anti-platelet therapies. The platelet aggregative devices market includes systems or instruments, reagents, and accessories and consumables used in platelet function testing. Platelet aggregation is a biological process where the platelet cells are involved in hemostasis. Hemostasis is a process of prevention of bleeding via vasoconstriction, rapid formation of a platelet plug, and clot formation.

Technavio's analysts forecast the global platelet aggregation devices market to grow at a CAGR of 17.02% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global platelet aggregation devices market for 2017-2021. To calculate the market size, the report considers sales, volume, value, and spares market.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Platelet Aggregation Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • F. Hoffmann-La Roche
  • Haemonetics
  • Helena Laboratories
  • Instrumentation Laboratory
  • Siemens Healthineers

Other Prominent Vendors

  • AggreDYNE
  • Bio/Data Corporation
  • Chrono-log Corporation
  • Drucker Diagnostics
  • LAbor BioMedical Technologies (LaBiTec)
  • Matis Medical
  • Sentinel Diagnostics
  • Sysmex Corporation

Market driver

  • Growing number of surgical procedures
  • For a full, detailed list, view our report

Market challenge

  • High cost of the devices
  • For a full, detailed list, view our report

Market trend

  • Increase in industry-academia collaborations
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product type

  • Systems
  • Reagents
  • Accessories and consumables

PART 07: Market segmentation by end-users

  • Hospitals
  • Diagnostic laboratories
  • Others

PART 08: Geographical segmentation

  • Platelet aggregation devices market in Americas
  • Platelet aggregation devices market in EMEA
  • Platelet aggregation devices market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Increase in industry-academia collaborations
  • Increase in online marketing services
  • Focus toward automated platelet aggregation testing procedures
  • Increasing blood transfusion surgical procedures

PART 12: Vendor landscape

  • Competitive scenario

PART 13: Key vendor analysis

  • F. Hoffmann-La Roche
  • Haemonetics
  • Helena Laboratories
  • Instrumentation Laboratory
  • Siemens Healthineers
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global platelet aggregation devices market 2016-2021 ($ millions)
  • Exhibit 02: Five forces analysis
  • Exhibit 03: Segmentation of global platelet aggregation devices market share by product 2016 (%)
  • Exhibit 04: Segmentation of global platelet aggregation devices market share by product 2016-2021 (%)
  • Exhibit 05: Segmentation of global platelet aggregation devices market revenue by product 2016-2021 ($ millions)
  • Exhibit 06: Global platelet aggregation systems market 2016-2021 ($ millions)
  • Exhibit 07: Global platelet aggregation reagents market 2016-2021 ($ millions)
  • Exhibit 08: Global platelet aggregation device accessories and consumables market 2016-2021 ($ millions)
  • Exhibit 09: Segmentation of global platelet aggregation devices market share by end-users 2016 (%)
  • Exhibit 10: Segregation of global platelet aggregation devices market share by geography 2016 (%)
  • Exhibit 11: Platelet aggregation devices market in Americas 2016-2021 ($ millions)
  • Exhibit 12: Platelet aggregation devices market in EMEA 2016-2021 ($ millions)
  • Exhibit 13: Platelet aggregation devices market in APAC 2016-2021 ($ millions)
  • Exhibit 14: Cost of platelet aggregation systems
  • Exhibit 15: Competitive structure analysis of global platelet aggregation devices market 2016
  • Exhibit 16: F. Hoffmann-La Roche: Key highlights
  • Exhibit 17: F. Hoffmann-La Roche: Strength assessment
  • Exhibit 18: F. Hoffmann-La Roche: Strategy assessment
  • Exhibit 19: F. Hoffmann-La Roche: Opportunity assessment
  • Exhibit 20: Haemonetics: Key highlights
  • Exhibit 21: Haemonetics: Strength assessment
  • Exhibit 22: Haemonetics: Strategy assessment
  • Exhibit 23: Haemonetics: Opportunity assessment
  • Exhibit 24: Helena Laboratories: Strength assessment
  • Exhibit 25: Helena Laboratories: Strategy assessment
  • Exhibit 26: Helena Laboratories: Opportunity assessment
  • Exhibit 27: Instrumental Laboratory: Key highlights
  • Exhibit 28: Instrumental Laboratory: Strength assessment
  • Exhibit 29: Instrumental Laboratory: Strategy assessment
  • Exhibit 30: Instrumental Laboratory: Opportunity assessment
  • Exhibit 31: Siemens Healthineers: Key highlights
  • Exhibit 32: Siemens Healthineers: Strength assessment
  • Exhibit 33: Siemens Healthineers: Strategy assessment
  • Exhibit 34: Siemens Healthineers: Opportunity assessment